Opioid Law: Your Rights And Settlement Claims

how can i make opioid law lawsuit settlements

As the opioid crisis continues to affect the United States, attorneys general have been leading the charge in combatting the epidemic by filing lawsuits against opioid manufacturers and distributors. States and local governments have targeted opioid makers and distributors in a bid to recoup billions in tax dollars spent dealing with the opioid crisis. As a result, states have reached agreements with companies to resolve legal claims against them for their role in the opioid crisis, with settlements totalling over $50 billion. This has led to substantial payments to states to address the epidemic, with funds being used for opioid treatment, prevention, and recovery programs.

Characteristics Values
Opioid Litigation Funds Available To States, cities, counties
Opioid Litigation Fund Used For Prevention, harm reduction, recovery, treatment efforts
Opioid Settlement Amount Over $50 billion
States With Settlements Texas, New York
Companies Involved in Settlements Johnson & Johnson, Endo, Teva, Allergan, AmerisourceBergen, Cardinal Health, McKesson, Mallinckrodt, Kroger, CVS, Walgreens, Walmart, Purdue Pharma, Sackler family
Terms of Settlements More oversight and accountability for distributors and pharmacies, independent monitor to prevent opioid deliveries where diversion and misuse occur, establish and fund an independent clearinghouse to track opioid distribution, ban on selling or promoting opioids for some companies
Settlement Decision-Making Process States identify priorities for reducing opioid-related deaths and investing in SUD prevention, treatment, and recovery infrastructure
Spending Authority Varies, can be state, local, abatement fund, or split

lawshun

Settlements with manufacturers, distributors, and pharmacies

Settlements with opioid manufacturers, distributors, and pharmacies are aimed at resolving legal claims and providing financial compensation to address the opioid crisis. Texas has taken a leading role in this regard, reaching final agreements with twelve companies, including manufacturers, distributors, and pharmacies, to address their role in the opioid crisis.

Settlements with Manufacturers

Four opioid manufacturers, Johnson & Johnson, Endo, Teva, and Allergan, have agreed to settlements with Texas and other states. These manufacturers will provide substantial payouts, with Johnson & Johnson contributing to a $26 billion settlement, along with McKesson ($7.4 billion), AmerisourceBergen ($6.1 billion), and Cardinal Health ($6 billion). These funds will primarily support health care and drug treatment programs to tackle the opioid crisis. Additionally, J&J, Endo, Teva, and Allergan will be prohibited from selling or promoting opioids as part of the industry-changing injunctive terms.

Settlements with Distributors

Three major pharmaceutical distributors, AmerisourceBergen, Cardinal Health, and McKesson, have also reached agreements. These distributors will be subject to increased oversight and accountability, including an independent monitor, to prevent the diversion and misuse of opioids. They will be required to establish a nationwide opioid distribution tracking system and flag suspicious orders. The distributors have also agreed to fund a new monitoring system to prevent communities from being inundated with high-risk medications.

Settlements with Pharmacies

Separate settlements have been reached with three pharmacies: CVS, Walgreens, and Walmart. These pharmacies will be subject to similar oversight as the distributors and will participate in the clearinghouse to track opioid distribution. The specific terms and amounts of these pharmacy settlements may vary, but they contribute to the overall financial support provided by the agreements with manufacturers, distributors, and pharmacies, which total over $50 billion in payments for states and local governments.

The settlements with manufacturers, distributors, and pharmacies are significant steps towards addressing the opioid crisis and ensuring accountability for the companies involved. These agreements provide much-needed funding for prevention, harm reduction, recovery, and treatment efforts. Additionally, the injunctive terms imposed on the companies aim to prevent similar crises from occurring in the future by implementing stricter controls and monitoring systems.

lawshun

State and local governments' lawsuits

State and local governments have been active in pursuing lawsuits and settlements against opioid manufacturers, distributors, and pharmacies to address the opioid crisis and hold responsible entities accountable. These legal actions are aimed at seeking compensation for the harm caused by deceptive marketing and misuse of opioid painkillers, which have led to widespread addiction and overdose-related deaths.

A notable example is the state of Georgia, which opted into opioid litigation against major pharmaceutical companies, including distributors McKesson, Cardinal Health, and AmerisourceBergen, as well as manufacturer Janssen Pharmaceuticals and its parent company, Johnson & Johnson. As a result of these settlements, Georgia will receive a combined $636 million, with the National Distributor Settlement funds disbursed over 18 years and the Janssen/J&J Settlement funds disbursed over 9 years. To oversee the allocation of these funds, Governor Kemp established the Georgia Opioid Settlement Advisory Committee (GOSAC), which includes representatives from state and local governments.

Michigan is another state that has successfully secured settlements from opioid manufacturers, distributors, and pharmacies, totaling nearly $1.6 billion. The state has specified that the majority of these funds, approximately 85%, must be spent on opioid remediation, including care, treatment, and programs to address the misuse and abuse of opioid products. Michigan has also joined the Walgreens National Opioid Settlement, which will provide additional funding over 15 years for eligible local governments to combat the opioid epidemic.

The lawsuits and settlements by state and local governments are intended to hold opioid manufacturers and distributors accountable for their role in the opioid crisis. The funds obtained from these settlements are crucial in supporting ongoing opioid-related work, including prevention, harm reduction, recovery, and treatment efforts. These settlements also aim to address the deceptive marketing practices of opioid painkillers, which downplayed their addictiveness and contributed to the widespread misuse of these drugs.

While the highly regulated nature of the pharmaceutical industry and FDA approval of opioid products may pose challenges to the success of these lawsuits, state and local governments remain committed to seeking justice and securing resources to address the opioid crisis. The collaboration between states and local subdivisions in these legal actions demonstrates a unified effort to hold responsible entities accountable and protect the well-being of their residents.

lawshun

State allocation of settlement funding

The allocation of opioid settlement funding varies across states. States have developed unique processes and administrative structures for allocating funding, identifying abatement needs, and promoting transparency in the use of funds. While some states have established spending structures for opioid settlement funds through legislation, others have issued executive orders or agreements with localities receiving the funds.

Thirty-five states have enacted legislation to set up spending structures for opioid settlement funds. Forty states have published agreements in partnership with localities to define roles, relationships, reporting structures, and fund distribution. These agreements may also designate entities responsible for distributing funds statewide. Advisory committees have been formed in thirty-three states to oversee and make recommendations for spending the state's share of opioid settlement funds.

The distribution of settlement funding across states, counties, and local entities varies. In some cases, a statewide abatement fund or the state itself controls over 50% of the settlement funding. In other instances, cities, counties, or a combination of state and local entities control the majority of the funds.

States are working to identify priorities for reducing opioid-related deaths and investing in substance use disorder (SUD) prevention, treatment, and recovery infrastructure. They are also focusing on aligning settlement funding with existing state plans and federal resources allocated to states through grants and block grants. States are required to report any spending that does not directly address opioid-related issues, such as attorneys' fees or administrative costs.

lawshun

Opioid abatement accounts and trust funds

Opioid abatement refers to efforts to reduce or fix the harm caused by the opioid crisis. Opioid abatement accounts and trust funds have been established to support programs associated with the prevention, treatment, and recovery of substance use disorders. These funds are typically created from settlements between state attorneys general and opioid manufacturers, distributors, and major pharmacy chains.

For example, the New Hampshire Opioid Abatement Trust Fund was established by House Bill 1639, along with an advisory commission to oversee its operations. The commission is responsible for ensuring that the fund is used to support programs that address the opioid crisis, including treatment, prevention, and recovery services. As of October 2024, the trust fund had awarded a total of $60,984,590.00 in grants, with an additional $14,454,071.10 distributed to 23 political subdivisions, including all ten NH counties and several cities. Each county, city, or town that receives a share of these funds decides how to use it to address the opioid crisis in their community and must submit a yearly report on their spending.

Similarly, the Texas Opioid Abatement Fund Council (OAFC) was formed to ensure that money recovered through statewide opioid settlement agreements is allocated fairly and spent on ending the opioid crisis in Texas. The OAFC is administratively attached to the Texas Comptroller's office, which provides the necessary staff and facilities to assist the Council in its duties.

The Principles for the Use of Funds from Opioid Litigation have been endorsed by over 60 organizations and incorporated into settlement planning in 25 states. These principles emphasize the importance of using settlement funds for prevention, harm reduction, recovery, and treatment efforts to support all at-risk communities.

lawshun

Industry-changing injunctive terms

The ongoing opioid crisis has led to numerous lawsuits and settlements, with over 3,000 state and local governments targeting opioid manufacturers and distributors. The primary aim of these legal actions is to recoup billions in tax dollars spent on dealing with the epidemic and its consequences.

Another example of an industry-changing injunctive term is the requirement for defendants to engage in industry-funded educational activities. These may include educational advertising campaigns to raise awareness about the harms of opioids, similar to the campaigns that have been implemented for tobacco.

In addition to these specific examples, the settlements also often include broad injunctive terms that aim to change the defendant's future behaviour and hold them accountable for any wrongdoing. These may include requirements to increase oversight and monitoring of opioid distribution and prescription practices, as well as to implement stricter ethical codes and guidelines to prevent harmful behaviour.

The inclusion of these industry-changing injunctive terms in opioid lawsuit settlements is intended to not only provide compensation for the harm caused but also to proactively prevent future harm and ensure that similar crises do not occur again.

Frequently asked questions

To make a claim, you must sign the Subdivision Settlement Participation Forms and return them to the relevant email address.

To be eligible for a settlement, your state must be participating in the agreements. Subdivisions can only participate if their state is also involved.

The amount of money received will depend on the number of subdivisions that join the settlements. The more subdivisions that join, the more money will be received.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment